Just over 8% of all hospital inpatients in England develop a healthcare associated infection, with this figure rising to 23% in intensive care units. Preventing and controlling the transmission of infection is a key priority for those involved in healthcare.
Led by researchers from Imperial College London, the new London consortium will look at healthcare associated infections from a wide range of angles, from exploring the molecular makeup of bacteria to addressing how best to bring about changes in practice across healthcare.
Its projects will span from springing into action if a particularly virulent strain of MRSA emerges, analysing its particular signature so it can be quickly detected and controlled, to finding the best ways to change the habits of hospital staff, patients and visitors to prevent infections from occurring and spreading.
The new initiative is one of two announced today by the UK Clinical Research Collaboration and it comprises Imperial College London, Imperial College Healthcare NHS Trust and the Health Protection Agency (HPA). One of its key aims is to ensure that benefits from the research reach patients as quickly and effectively as possible.
Dr Alison Holmes, co-lead on the project, is the Director of Infection Control and Prevention at Imperial College Healthcare NHS Trust and a researcher in the Division of Investigative Science at Imperial College London. Dr Holmes explained:
“It’s vital that we carry out basic science to gain a better understanding of existing infections and newly emerging strains, and that we identify the very best ways to fight them. However, it’s only through figuring out how to make people change their habits and practices across our hospitals and the wider healthcare community that we can improve the picture across the UK.
“This is a crucial part of our new project – to ensure that we’re not just coming up with great new ideas, we’re making sure they become part of practice on the wards and in how we manage our hospitals,” added Dr Holmes.
At the laboratory level, the researchers aim to use state of the art molecular tools in order to answer some of the most pressing questions about healthcare associated infection. For example, if a particularly virulent strain of an infection such as MRSA emerges, researchers will set to work to explore how this differs in its genetic and protein makeup from other strains. They then aim to develop a test that hospitals can use to detect the strain so they can prevent it infecting their patients.
They will also look at issues such as how easily the bacteria can be transmitted, by tagging individual bugs with bioluminescence to see how they cross between hospital equipment such as latex gloves and identify the best strategies for preventing such spread.
Another strand of the project will involve healthcare management experts from Imperial College’s Tanaka Business School to explore how to change the behaviour of individuals and whole organisations in the NHS, so that new innovations are adopted rapidly and best practice is embedded and sustained.
Researchers will also be exploring the most effective messages to encourage everyone, from senior consultants to cleaning staff, to prevent infection, improve antibiotic practice and take the relevant steps to keep infection under control. Another part of the project will investigate how to better educate pharmacists about countering resistance to antibiotics.
The researchers will also be looking at how the NHS can use existing and new data to analyse infections at every level, from whole UK regions to individual hospital wards, in order to reveal where there are particular infection problems and explore the causes behind these and target action at the earliest opportunity.
Professor Steve Smith, Principal of the Faculty of Medicine at Imperial College London and Chief Executive of Imperial College Healthcare NHS Trust, said: "All of us involved in running hospitals want to make sure that our patients receive the best possible care and a key aspect of this is making sure we minimise their risk of contracting an infection.
"As the UK's first Academic Health Science Centre, Imperial College London and Imperial College Healthcare NHS Trust are in the perfect position to not only research the best ways of tackling these infections, but to make sure patients see their care improving in our own hospitals and across the UK as a result of our academic work," added Professor Smith.
Spread over five years, the £4.2m funding will enable Imperial College to create nine new PhD fellows specialising in a range of fields addressing infection prevention, from organisational development and behaviour; to epidemiology, surveillance and modelling; to bacterial genetics, molecular typing and pathogenesis.
New appointments will include three post doctoral researchers, a consultant-level infectious diseases pharmacist, a consultant level infection control nurse, an academic manager and an education lead who will oversee research and development in the multi professional education and training programme.
The HPA will also be funding the development of an HPA centre linked to the consortium at Imperial College Healthcare NHS Trust, which will provide two new posts.
The new award is jointly made by the Biotechnology and Biological Sciences Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust.
This is the first round of funding awarded under a UK Clinical Research Collaboration joint initiative. The initiative was set up to bring together new multi-disciplinary research groups focused on high quality collaborative research addressing national priorities in the field of microbiology and infection.
Laura Gallagher | alfa
Studying outdoors is better
06.02.2018 | Technische Universität München
Classroom in Stuttgart with Li-Fi of Fraunhofer HHI opened
03.11.2017 | Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences